文献速递妇科

良性腹腔镜子宫切除术中普遍膀胱镜检查的成本效果分析

Cost-effectiveness Analysis of Universal Cystoscopy at the Time of Benign Laparoscopic Hysterectomy.
PubMed 文献 · J Minim Invasive Gynecol · 2020-12-11

该研究采用决策树模型,评估腹腔镜子宫切除术后延迟识别或术中识别下尿路损伤(LUTI)的成本与质量调整生命年。成本基于Medicare全国报销标准,概率与效用来自已发表文献,并进行了阈值分析与蒙特卡洛模拟。结论显示,在当代临床环境中(LUTI率约1.8%),普遍膀胱镜检查具有成本效果,在高危人群(如子宫内膜异位症或盆腔器官脱垂)中可能节约成本。

要点

  • 普遍膀胱镜检查在LUTI率超过0.80%时具有成本效果。
  • 当LUTI率为2.3%或4.0%时,普遍膀胱镜检查具成本效果的概率分别为93.9%和99.6%。
  • 在高危人群(如子宫内膜异位症或盆腔器官脱垂)中,普遍膀胱镜检查可能节约成本。

核心结论

  • 在模型中,普遍膀胱镜检查是腹腔镜子宫切除术的首选方法,在当代临床环境(LUTI率估计为1.8%)中具有成本效果,在高危人群中可能节约成本。

研究设计与样本

  • 决策树模型,模拟因良性适应症行腹腔镜子宫切除术的个体,概率与效用来自已发表文献,成本来自Medicare全国报销标准,并进行蒙特卡洛模拟。

主要发现

  • 常规护理下腹腔镜子宫切除术的总直接医疗成本为8831至9149美元,普遍膀胱镜检查下为8944至9068美元。
  • 当LUTI率为0.44%时,普遍膀胱镜检查仅在17.1%的模拟中具有成本效果,增量成本为111至131美元。
  • 当LUTI率为2.3%或4.0%时,普遍膀胱镜检查具成本效果的比例分别为93.9%和99.6%,若术中膀胱镜检查对输尿管损伤的敏感性分别超过65%或31%,可能节约成本。
  • 估计每例子宫切除术可节约18至95美元。
  • 阈值分析假设平均膀胱镜检查敏感性时,LUTI率超过0.80%则普遍膀胱镜检查具有成本效果。

关键数值与推荐

  • LUTI率超过0.80%时,普遍膀胱镜检查具有成本效果。
  • LUTI率为0.44%时,普遍膀胱镜检查仅在17.1%的模拟中具有成本效果。
  • LUTI率为2.3%时,普遍膀胱镜检查具成本效果的比例为93.9%,若膀胱镜检查对输尿管损伤的敏感性超过65%可能节约成本。
  • LUTI率为4.0%时,普遍膀胱镜检查具成本效果的比例为99.6%,若敏感性超过31%可能节约成本。
  • 若LUTI率低于0.75%,估计增量成本适度,最高达每例131美元。

临床怎么用

  • 在规划普遍膀胱镜检查政策时,管理者和提供者应考虑当地的LUTI率和实践模式。
  • 对于LUTI率估计为1.8%的当代临床环境,普遍膀胱镜检查是首选方法。
  • 在高危人群(如子宫内膜异位症或盆腔器官脱垂)中,普遍膀胱镜检查可能节约成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To estimate the rate of lower urinary tract injury (LUTI) and percentage of LUTI needing to be recognized intraoperatively to make universal cystoscopy cost-effective and cost-saving during laparoscopic hysterectomy. DESIGN: A decision tree model was used to estimate the costs and quality-adjusted life years associated with delayed or intraoperative recognition of LUTI at the time of laparoscopic hysterectomy. Probabilities and utilities were estimated from published literature. Costs were estimated from Medicare national reimbursement schedules. Threshold analyses estimated the LUTI rate and cystoscopy sensitivity that would make universal cystoscopy cost-effective or cost-saving. Monte Carlo simulations were performed. SETTING: US healthcare system. PATIENTS: Individuals undergoing laparoscopic hysterectomy for benign indications. INTERVENTIONS: Theoretic implementation of a universal cystoscopy policy. MEASUREMENTS AND MAIN RESULTS: The total direct medical costs of laparoscopic hysterectomy under usual care were $8831 to $9149 and under universal cystoscopy were $8944 to $9068. When low LUTI rates (0.44%; estimated using sample-weighted estimates of retrospective and prospective data) were assumed, universal cystoscopy was only cost-effective in 17.1% of the simulations; the incremental cost was estimated to be $111 to $131. With median LUTI rates (2.3%) or high LUTI rates (4.0%; estimated using only prospective data with universal screening), the universal cystoscopy strategy was cost-effective in 93.9% and 99.6% of the simulations, respectively, and potentially cost-saving if the sensitivity of intraoperative cystoscopy for ureteral injury exceeded 65% or 31%, respectively. The estimated potential savings were $18 to $95 per hysterectomy. In threshold analysis assuming the average cystoscopy sensitivity rate, universal cystoscopy is estimated to be cost-effective when the LUTI rate exceeds 0.80%. CONCLUSION: In our model, universal cystoscopy is the preferred approach for laparoscopic hysterectomy and is estimated to be cost-effective in contemporary clinical settings where the LUTI rate is estimated to be 1.8% and potentially cost-saving among higher-risk populations, including those with endometriosis or pelvic organ prolapse. If the LUTI rates are less than 0.75%, the estimated incremental costs are modest-up to $131 per case. Administrators and providers should consider the local LUTI rates and practice patterns when planning implementation of a universal cystoscopy policy.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Luchristt D, Geynisman-Tan J, Mueller MG, et al. Cost-effectiveness Analysis of Universal Cystoscopy at the Time of Benign Laparoscopic Hysterectomy. J Minim Invasive Gynecol. 2020. PMID: 33310171. doi:10.1016/j.jmig.2020.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。